| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.003 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.005 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.006 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.007 |